Kringle Pharma, Inc. (TYO:4884)
Japan flag Japan · Delayed Price · Currency is JPY
510.00
-64.00 (-11.15%)
Nov 18, 2026, 11:10 AM JST

Kringle Pharma Cash Flow Statement

Millions JPY. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Net Income
-811-914-754-852-330
Loss (Gain) From Sale of Investments
1----
Other Operating Activities
-130155147341
Change in Accounts Receivable
--7-76
Change in Inventory
704469-14-34
Change in Accounts Payable
70-16-13511821
Change in Other Net Operating Assets
1071-3-8111
Operating Cash Flow
-563-755-661-68915
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Cash Acquisitions
-16----
Investment in Securities
--131-121-120-254
Other Investing Activities
--23---
Investing Cash Flow
-16-154-121-120-254

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Issuance of Common Stock
6438483869603
Financing Cash Flow
6438483869603

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Foreign Exchange Rate Adjustments
-1----
Miscellaneous Cash Flow Adjustments
-1--1--
Net Cash Flow
62-82555-740364

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Levered Free Cash Flow
-258.75-581.13-552.63-538.63-185.25
Unlevered Free Cash Flow
-258.75-581.13-552.63-538.63-185.25

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Cash Income Tax Paid
1111-6
Change in Working Capital
24729-62164